Patent · US Expired

Certain as-triazino 4,3-a! 1,4!benzodiazepine-1,2-dione compounds

US4073784A · kind A · utility

2Cited by
6References
10Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 9, 1977
Grant dateFeb 14, 1978
Priority date
Expiry dateMar 9, 1997

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D243/20
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds of the formula V ##STR1## wherein R.sub.1 is hydrogen, alkyl of 1 to 3 carbon atoms, inclusive; ##STR2## in which n is 2 or 3; and X is hydrogen, fluoro or chloro; wherein R.sub.2 is hydrogen, methyl or ethyl; wherein R.sub.3 is hydrogen, fluoro, chloro, bromo, trifluoromethyl and nitro; and wherein Ar is phenyl, o-chlorophenyl, o-fluorophenyl, 2,6-difluorophenyl or 2-pyridyl are prepared by treating a hydrazino compound of the formula: ##STR3## WHEREIN Ar, R.sub.2 and R.sub.3 are defined as above with an alkyl oxalyl chloride and cyclizing the obtained products. Compound V, including the pharmacologically acceptable acid addition salt thereof, have sedative, anxiolytic and muscle-relaxing activity and can be used for the treatment of anxieties or muscle strains of mammals, including man.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.